Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000035

President and CEO acquired 7,052 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-10-08 Exercise or conversion : show line 1 in the form +7,052 $14.18 $99,997 638,246 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-10-08 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −7,052 $14.18 2022-12-26 7,052 16,149 D
Loading xslF345X03/edgar.xml…